For many emerging biotech companies, engaging a Contract Research Organization (CRO) feels like a milestone that comes later in development. The assumption is often that CRO discussions should begin once a study plan is finalized, funding is secured, and execution is ready to begin. In reality, however, some of the most valuable CRO conversations happen much earlier. Early engagement gives ... Read More The post Why It’s Never Too Early to Start Conversations with CROs appeared first on Lovelace Biomedical .